Core Viewpoint - Cardinal Health has announced the acquisition of Solaris Health, a leading urology management services organization, to enhance its multi-specialty growth strategy and expand its Urology Alliance [1][2][5]. Company Overview - Cardinal Health will provide approximately $1.9 billion in cash for the acquisition and will own about 75% of The Specialty Alliance post-acquisition [3]. - Solaris Health supports over 750 providers across more than 250 practice locations in 14 states, enhancing Cardinal Health's reach in local communities [4][11]. - The acquisition is expected to be slightly accretive to Cardinal Health's non-GAAP earnings per share in the first 12 months following the close [6]. Strategic Importance - The acquisition aligns with Cardinal Health's focus on accelerating specialty growth, particularly in urology, which is viewed as an attractive specialty [5][7]. - The combined capabilities of The Specialty Alliance and Solaris Health will empower physicians to focus on patient care, improving outcomes through integrated and coordinated care [5][6]. Financial Aspects - Cardinal Health plans to finance the acquisition through a combination of cash on hand and new debt financing, while maintaining a disciplined capital allocation framework [7][8]. - The company expects to remain within its targeted leverage range by the end of fiscal 2026 despite the acquisition [8]. Leadership Transition - Following the acquisition, Dr. Gary Kirsh, CEO of Solaris Health, will retire from his role and serve as a Senior Advisor to Cardinal Health [5][6].